MktsMarkets

CME Group Inc.
NASDAQ: CMEKey statistics
CME News
Stories mentioning CME from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,880,100 | 1,648,700 | 1,537,600 | 1,692,000 | 1,642,300 | 1,525,300 | 1,584,400 | 1,532,500 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 1,309,700 | 1,019,600 | 972,600 | 1,129,300 | 1,108,000 | 947,100 | 1,024,200 | 1,000,600 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (1,246,900) | (1,262,400) | (1,396,600) | (1,372,400) | (802,400) | (837,500) | (920,000) | (936,900) |
| Pretax Income | 1,510,900 | 1,578,400 | 1,177,000 | 1,330,300 | 1,244,800 | 1,096,600 | 1,176,900 | 1,154,500 |
| Tax Provision | 356,600 | 395,500 | 269,000 | 305,200 | 288,600 | 222,000 | 264,100 | 271,300 |
| Net Income (Loss) | ||||||||
| Earnings Per Share (Basic) | 3.25 | 0.00 | 2.49 | 2.81 | 2.63 | 0.00 | 2.51 | 2.43 |
| Earnings Per Share (Diluted) | 3.18 | 0.00 | 2.49 | 2.81 | 2.62 | 0.00 | 2.50 | 2.42 |
| Weighted Average Shares Outstanding (Basic) | 359,318 | 359,648 | 359,686 | 359,658 | 359,613 | 359,389 | 359,400 | 359,330 |
| Weighted Average Shares Outstanding (Diluted) | 363,208 | 360,310 | 360,422 | 360,355 | 360,227 | 359,944 | 359,989 | 359,869 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CME
CME Group Inc. (NASDAQ: CME) is a stock listed on the Nasdaq Stock Market under the ticker symbol CME. It last traded at $304.52 (Nov 9, 2026, 4:00 PM ET), down 0.5% on the day. That gives CME a market capitalisation of $108.5B and a price-to-earnings ratio of 24.6.
Over the past 52 weeks CME has traded between $218.31 and $329.16.
Revenue for the quarter ended Mar 31, 2026 was $1.9B. Revenue was up 14.5% from $1.6B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | $1.9B | — |
| Dec 31, 2025 | $1.6B | — |
| Sep 30, 2025 | $1.5B | — |
| Jun 30, 2025 | $1.7B | — |
From CME’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…